SVRA
Price:
$5.25
Market Cap:
$1.07B
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
Industry
Biotechnology
IPO Date
2017-04-28
Stock Exchange
NASDAQ
Ticker
SVRA
According to Savara Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.06B. This represents a change of 31.53% compared to the average of 809.66M of the last 4 quarters.
The mean historical Enterprise Value of Savara Inc. over the last ten years is 385.45M. The current 1.06B Enterprise Value has changed 27.53% with respect to the historical average. Over the past ten years (40 quarters), SVRA's Enterprise Value was at its highest in in the December 2025 quarter at 1.34B. The Enterprise Value was at its lowest in in the March 2016 quarter at 13.59M.
Average
385.45M
Median
231.60M
Minimum
20.40M
Maximum
1.34B
Discovering the peaks and valleys of Savara Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.14%
Maximum Annual Enterprise Value = 1.34B
Minimum Annual Increase = -54.47%
Minimum Annual Enterprise Value = 20.40M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 1.34B | 115.74% |
| 2024 | 620.06M | -20.13% |
| 2023 | 776.37M | 268.23% |
| 2022 | 210.84M | 33.58% |
| 2021 | 157.84M | 123.54% |
| 2020 | 70.61M | -54.47% |
| 2019 | 155.07M | -38.55% |
| 2018 | 252.36M | -0.34% |
| 2017 | 253.23M | 1.14% |
| 2016 | 20.40M | 70.15% |
The current Enterprise Value of Savara Inc. (SVRA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
911.38M
5-year avg
620.56M
10-year avg
385.45M
Savara Inc.’s Enterprise Value is less than Tyra Biosciences, Inc. (1.87B), greater than Rezolute, Inc. (237.68M), less than ProKidney Corp. (1.35B), greater than Kura Oncology, Inc. (635.41M), less than Nanobiotix S.A. (1.43B), greater than EyePoint Pharmaceuticals, Inc. (1.02B), greater than GH Research PLC (681.60M), greater than Bicara Therapeutics Inc. Common Stock (881.57M), less than Geron Corporation (1.18B), less than Tango Therapeutics, Inc. (1.93B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.87B | $1.95B | |
| 237.68M | $248.34M | |
| 1.35B | $633.17M | |
| 635.41M | $764.05M | |
| 1.43B | $1.60B | |
| 1.02B | $1.10B | |
| 681.60M | $927.34M | |
| 881.57M | $1.05B | |
| 1.18B | $1.01B | |
| 1.93B | $2.01B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Savara Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Savara Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Savara Inc.'s Enterprise Value?
What is the highest Enterprise Value for Savara Inc. (SVRA)?
What is the 3-year average Enterprise Value for Savara Inc. (SVRA)?
What is the 5-year average Enterprise Value for Savara Inc. (SVRA)?
How does the current Enterprise Value for Savara Inc. (SVRA) compare to its historical average?